A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

Figure 10

The construction of two gene signature and the assessment of its prognosis value. (a) LASSO coefficient profiles of the three genes having a correlation with survival. (b) We drew a coefficient profile plot against the log (lambda) sequence in the LASSO model. (c) The distributions of the status, survival time, and risk score of patients from TCGA datasets. (d) Kaplan-Meier curves of the gene signature from TCGA datasets. (e) The prognosis gene signature’s time-dependent ROC curves from TCGA datasets.

(a)

(b)

(c)

(d)

(e)